POSSIBLE LACK OF FULL CROSS-RESISTANCE OF 5HT(3) ANTAGONISTS - A PILOT-STUDY

被引：3

作者：

DEBOER, M

DEWIT, R

STOTER, G

VERWEIJ, J

机构：

[1] Department of Medical Oncology, Rotterdam Cancer Institute/Dr. Daniel den Hoed Kliniek, Rotterdam, 3075 EA

来源：

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1995年 / 121卷 / 02期

关键词：

D O I：

10.1007/BF01202225

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We investigated the potential of cross-over to the serotonin receptor (5HT3) antagonist ondansetron after protection failure with tropisetron. Several cases of complete protection were observed. These limited data suggest that there is an indication for retreatment with a different 5HT3 antagonist after an initial failure to another and also stress the need and relevance for comparative studies between 5HT3 antagonists.

引用

页码：126 / 127

页数：2

共 4 条

[1] Ondansetron Compared with High-Dose Metoclopramide in Prophylaxis of Acute and Delayed Cisplatin-Induced Nausea and Vomiting - A Multicenter, Randomized, Double-Blind, Crossover Study [J].

Demulder, PHM ;

Seynaeve, C ;

Vermorken, JB ;

Vanliessum, PA ;

Molsjevdevic, S ;

Allman, EL ;

Beranek, P ;

Verweij, J .

ANNALS OF INTERNAL MEDICINE, 1990, 113 (11) :834-840

[2] COMPARISON OF THE 5-HYDROXYTRYPTAMINE3 (SEROTONIN) ANTAGONIST ONDANSETRON (GR-38032F) WITH HIGH-DOSE METOCLOPRAMIDE IN THE CONTROL OF CISPLATIN-INDUCED EMESIS [J].

MARTY, M ;

POUILLART, P ;

SCHOLL, S ;

DROZ, JP ;

AZAB, M ;

BRION, N ;

PUJADELAURAINE, E ;

PAULE, B ;

PAES, D ;

BONS, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (12) :816-821

[3]

SEYNAEVE C, 1991, ANTI-CANCER DRUG, V19, P203

[4]

1993, J CLIN ONCOL, V11, P396

← 1 →